Navegar

Colección

Datos Estadísticas

Lista de

tumor volume
20
"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334
"Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model" (2017) Marostica, L.L.;de Barros, A.L.B.;Oliveira, J. (...)Simões, C.M.O. Toxicology and Applied Pharmacology. 329:272-281
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154
"Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer" (2015) Zalazar, F.;De Luca, P.;Gardner, K. (...)De Siervi, A. Current Pharmaceutical Biotechnology. 16(6):553-563
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262
"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795
"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12
"Effect of SOM230 (Pasireotide) on corticotropic cells: Action in dogs with Cushing's disease" (2011) Castillo, V.;Theodoropoulou, M.;Stalla, J. (...)Arzt, E. Neuroendocrinology. 94(2):124-136
"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international collaborative study" (2010) Daly, A.F.;Tichomirowa, M.A.;Petrossians, P. (...)Beckers, A. Journal of Clinical Endocrinology and Metabolism. 95(11):E373-E383
"Tumor control and normal tissue complications in BNCT treatment of nodular melanoma: A search for predictive quantities" (2009) González, S.J.;Casal, M.;Pereira, M.D. (...)Liberman, S.J. Applied Radiation and Isotopes. 67(7-8SUPPL):S153-S156
"Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy" (2008) Vittar, N.B.R.;Prucca, C.G.;Strassert, C. (...)Rivarola, V.A. International Journal of Biochemistry and Cell Biology. 40(10):2192-2205
"Pituitary action of cytokines: Focus on BMP-4 and gp130 family" (2007) Giacomini, D.;Acuña, M.;Gerez, J. (...)Arzt, E. Neuroendocrinology. 85(2):94-100
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"Retinoic acid as a novel medical therapy for Cushing's disease in dogs" (2006) Castillo, V.;Giacomini, D.;Páez-Pereda, M. (...)Arzt, E. Endocrinology. 147(9):4438-4444
"New mechanisms involved in the pathogenesis of pituitary adenomas " (2003) Giacomini, D.;Paez-Pereda, M.;Refojo, D. (...)Arzt, E. Medicina. 63(2):147-150